prof. dr. Griet Glorieux
- ORCID iD
- 0000-0002-7641-4707
Show
Sort by
-
Modulation of blood pressure through microbiome exchange between milan normotensive and hypertensive strains of rats
(2023) NEPHROLOGY DIALYSIS TRANSPLANTATION. In Nephrology Dialysis Transplantation 38(Supplement 1). p.I975-I976 -
Identification of glycosylated IGF2 in human urinary peptidome and its association with CKD
(2023) NEPHROLOGY DIALYSIS TRANSPLANTATION. In Nephrology Dialysis Transplantation 38(Supplement 1). p.I442-I444 -
Impact of symbiotics on uremic toxins production, renal function and pew syndrome in shime and CKD mice models
(2023) NEPHROLOGY DIALYSIS TRANSPLANTATION. In Nephrology Dialysis Transplantation 38(Supplement 1). p.I419-I420 -
- Journal Article
- A1
- open access
Prognosis and personalized in silico prediction of treatment efficacy in cardiovascular and chronic kidney disease : a proof-of-concept study
-
Uremic toxins are associated with immune-senescence and immune-exhaustion in hemodialysis patients
(2023) NEPHROLOGY DIALYSIS TRANSPLANTATION. In Nephrology Dialysis Transplantation 38(Supplement 1). p.I819-I820 -
- Journal Article
- A1
- open access
Immunosenescence and immune exhaustion are associated with levels of protein-bound uremic toxins in patients on hemodialysis
-
Predictive value of protein-bound uremic toxins for heart failure events in patients with chronic kidney disease
-
- Journal Article
- A1
- open access
Machine learning-based urine peptidome analysis to predict and understand mechanisms of progression to kidney failure
-
Role of the microbiome in gut-heart-kidney cross talk
-
- Journal Article
- A1
- open access
Glycosylation analysis of urinary peptidome highlights IGF2 glycopeptides in association with CKD
-
- Journal Article
- A1
- open access
Time-averaged concentration estimation of uraemic toxins with different removal kinetics : a novel approach based on intradialytic spent dialysate measurements
-
- Journal Article
- A1
- open access
Gut microbiome studies in CKD : opportunities, pitfalls and therapeutic potential
-
- Journal Article
- A2
- open access
Effect of simplified dietary advice on nutritional status and uremic toxins in chronic kidney disease participants
-
- Journal Article
- A1
- open access
The effect of ss-glucan prebiotic on kidney function, uremic toxins and gut microbiome in stage 3 to 5 chronic kidney disease (CKD) predialysis participants : a randomized controlled trial
-
- Journal Article
- A1
- open access
Treatment with paracetamol can interfere with the intradialytic optical estimation in spent dialysate of uric acid but not of indoxyl sulfate
-
- Journal Article
- A1
- open access
What if not all metabolites from the uremic toxin generating pathways are toxic? A hypothesis
-
- Journal Article
- A1
- open access
Contribution of hypoalbuminemia and anemia to the prognostic value of plasma p-cresyl sulfate and p-cresyl glucuronide for cardiovascular outcome in chronic kidney disease
-
A home-based exercise and physical activity intervention after kidney transplantation : impact of exercise intensity : the Phoenix-kidney study protocol
(2022) NEPHROLOGY DIALYSIS TRANSPLANTATION. In Nephrology Dialysis Transplantation 37(Supplement 3). p.i433-i433 -
- Journal Article
- A1
- open access
The role of advanced glycation end products and its soluble receptor in kidney diseases
-
- Journal Article
- A1
- open access
Dietary advanced glycation end products in an elderly population with diabetic nephropathy : an exploratory investigation
-
Potassium and fiber : a controversial couple in the nutritional management of children with chronic kidney disease
-
- Journal Article
- A1
- open access
Syndecan-1 and free indoxyl sulfate levels are associated with miR-126 in chronic kidney disease
-
- Journal Article
- A1
- open access
A low aromatic amino-acid diet improves renal function and prevent kidney fibrosis in mice with chronic kidney disease
-
- Journal Article
- A1
- open access
Gut microbiome profiling uncovers a lower abundance of Butyricicoccus in advanced stages of chronic kidney disease
-
Association between carbamylated albumin, gut microbiota and their derived metabolites in chronic kidney disease
(2021) NEPHROLOGY DIALYSIS TRANSPLANTATION. In Nephrology Dialysis Transplantation 36(Supplement 1). p.291-291 -
- Conference Paper
- C3
- open access
Potassium and fibre : a controversial couple in the nutritional management of children with chronic kidney disease
-
- Journal Article
- A1
- open access
Measured glomerular filtration rate : the query for a workable golden standard technique
-
- Journal Article
- A1
- open access
Gut microbiota and their derived metabolites, a search for potential targets to limit accumulation of protein-bound uremic toxins in chronic kidney disease
-
- Journal Article
- A1
- open access
Uremic toxins and cardiovascular system
-
- Journal Article
- A1
- open access
Data sharing under the General Data Protection Regulation : time to harmonize law and research ethics?
-
Dietary fiber intake and gut-derived uraemic toxins in a Belgian paediatric CKD cohort
-
- Journal Article
- A1
- open access
Dietary fibre intake is associated with serum levels of uraemic toxins in children with chronic kidney disease
-
Free p-cresyl sulfate shows the highest association with cardiovascular outcome in chronic kidney disease
-
- Journal Article
- A1
- open access
The impact of intradialytic cycling on the removal of protein-bound uraemic toxins : a randomised cross-over study
-
Dietary fibre intake is low in paediatric chronic kidney disease patients but its impact on levels of gut-derived uraemic toxins remains uncertain
-
The urinary proteomics classifier chronic kidney disease 273 predicts cardiovascular outcome in patients with chronic kidney disease
-
Spot urine versus 24-hour urine collection for estimation of the generation of uremic toxins originating from gut microbial metabolism : reply
-
A low aromatic amino-acid diet improves renal function and prevents kidney fibrosis in mice with chronic kidney disease
(2020) NEPHROLOGY DIALYSIS TRANSPLANTATION. In Nephrology dialysis transplantation 35(Supplement 3). p.1248-1248 -
- Journal Article
- A1
- open access
Effects of fecal microbiota transplantation on composition in mice with CKD.
-
Identification and quantification of uremic toxin precursors-generating gut bacteria in chronic kidney disease
(2020) NEPHROLOGY DIALYSIS TRANSPLANTATION. In Nephrology dialysis transplantation 35(Supplement 3). p.1025-1025 -
- Journal Article
- A1
- open access
Exploring the possibilities of infrared spectroscopy for urine sediment examination and detection of pathogenic bacteria in urinary tract infections
-
Review on uremic toxins : classification, concentration, and interindividual variability (vol 63, pg 1934, 2003)
-
Health utility but not uremic toxins are associated with one year mortality in HD patients
-
- Journal Article
- A1
- open access
Gut-derived metabolites and their role in immune dysfunction in chronic kidney disease
-
- Journal Article
- A1
- open access
Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease see
-
- Journal Article
- A1
- open access
Isolation and quantification of uremic toxin precursor-generating gut bacteria in chronic kidney disease patients
-
- Journal Article
- A1
- open access
Serum levels and removal by haemodialysis and haemodiafiltration of tryptophan-derived uremic toxins in ESKD patients
-
- Journal Article
- A1
- open access
Carbamoylated nail proteins as assessed by near-infrared analysis are associated with load of uremic toxins and mortality in hemodialysis patients
-
- Journal Article
- A1
- open access
Difference in profiles of the gut-derived tryptophan metabolite indole acetic acid between transplanted and non-transplanted patients with chronic kidney disease
-
- Journal Article
- A1
- open access
Comparison of five assays for DNA extraction from bacterial cells in human faecal samples
-
- Journal Article
- A1
- open access
UV fluorescence-based determination of urinary advanced glycation end products in patients with chronic kidney disease
-
Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population
-
Uremic toxins promote accumulation of oxidized protein and increased sensitivity to hydrogen peroxide in endothelial cells by impairing the autophagic flux
-
- Conference Paper
- C3
- open access
Uremic toxin concentrations are related to residual kidney function in the pediatric hemodialysis population
-
Concentrations of p-cresyl - and indoxyl sulfate and their precursors in different stages of chronic kidney disease : from feces to urine
-
- Journal Article
- A1
- open access
An in-vitro assay using human spermatozoa to detect toxicity of biologically active substances
-
- Journal Article
- A1
- open access
Selective transport of protein-bound uremic toxins in erythrocytes
-
- Journal Article
- A1
- open access
Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease
-
- Journal Article
- A1
- open access
Uremic toxin concentrations are related to residual kidney function in the pediatric hemodialysis population
-
- Journal Article
- A1
- open access
Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients
-
The role of the intestinal microbiota in uremic solute accumulation : a focus on sulfur compounds
-
Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury
-
- Journal Article
- A1
- open access
Gut microbiota dynamics and uraemic toxins : one size does not fit all
-
Towards optimised dialysis removal of protein-bound uraemic toxins
-
- Journal Article
- A1
- open access
Association between protein-bound uremic toxins and asymptomatic cardiac dysfunction in patients with chronic kidney disease
-
Gut-derived metabolites and chronic kidney disease : the forest (f)or the trees?
-
Residual urine production decreases concentrations of protein-bound uremic toxins more effectively than increased convection with hemodiafiltration
-
Concentrations of protein-bound uremic toxins in children on conventional HD are mainly affected by residual urine production
-
Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate
-
Value of urinary proteome-based classifier associated with chronic kidney disease and its progression in the prognosis of a patient-relevant endpoint, mortality
-
- Journal Article
- A1
- open access
Biochemical and clinical impact of organic uremic retention solutes : a comprehensive update
-
- Journal Article
- A1
- open access
Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up
-
- Journal Article
- A1
- open access
Deleting death and dialysis : conservative care of cardio-vascular risk and kidney function loss in chronic kidney disease (CKD)
-
Endothelial glycocalyx damage in CKD : role of the uremic toxin indoxyl sulfate
-
A plea for more uremic toxin research in children with chronic kidney disease
-
- Journal Article
- A1
- open access
Binding of bromocresol green and bromocresol purple to albumin in hemodialysis patients
-
Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease
-
Hereditary polycystic kidney disease is characterized by lymphopenia across all stages of kidney dysfunction : an observational study
-
Early and asymptomatic cardiac dysfunction in chronic kidney disease
-
Urea and chronic kidney disease : the comeback of the century? (in uraemia research)
-
Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population
-
Not creatinine but protein bound uraemic toxins are predominant in the prediction of QOL in children with CKD
-
Exploring protein binding of different uraeic toxins
-
An exploration of the association between uraemic toxin concentrations and quality of life in children with chronic kidney disease
-
Uraemic toxin accumulation in paediatric CKD patients is only partially reflected by estimated GFR
-
An exploration of the association between uraemic toxin concentrations and quality of life in children with chronic kidney disease
-
The place of large pore membranes in the treatment portfolio of patients on hemodialysis
-
- Journal Article
- A1
- open access
Prediction of chronic kidney disease stage 3 by CKD273, a urinary proteomic biomarker
-
p-cresol sulfate and indoxyl sulfate: some clouds are gathering in the uremic toxin sky
-
Quantification of carbamylated albumin in serum based on capillary electrophoresis
-
- Journal Article
- A1
- open access
Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients
-
p-Cresyl glucuronide is a major metabolite of p-cresol in mouse : in contrast to p-cresyl sulphate, p-cresyl glucuronide fails to promote insulin resistance
-
Exploring protein binding of different uraemic toxins
-
Exploring binding characteristics and the related competition of different protein-bound uremic toxins
-
Effect of sample temperature, pH, and matrix on the percentage protein binding of protein-bound uraemic toxins
-
Exploring binding characteristics and related competition of different uraemic toxins
-
- Journal Article
- A1
- open access
Metabolic profiling of human plasma and urine in chronic kidney disease by hydrophilic interaction liquid chromatography coupled with time-of-flight mass spectrometry : a pilot study
-
- Journal Article
- A1
- open access
p-Cresyl sulfate
-
Estimated GFR poorly reflects the concentration of various uremic toxins in pediatric CKD patients
-
Intestinal metabolites, chronic kidney disease and renal transplantation : Enigma Variations?
-
- Journal Article
- A1
- open access
New low-flux mixed matrix membranes that offer superior removal of protein-bound toxins from human plasma
-
- Miscellaneous
- open access
Response to Tsikas et al. comments on Boelaert et al. Determination of asymmetric and symmetric dimethylarginine in serum from patients with chronic kidney disease: UPLC-MS/MS versus ELISA. Toxins 2016, 8, 149
-
Estimated GFR poorly reflects the concentration of various uremic toxins in pediatric CKD patients
-
Concentrations of representative uremic toxins in a healthy versus uremic pediatric population
-
- Journal Article
- A1
- open access
Development of a MALDI MS-based platform for early detection of acute kidney injury
-
Clinical management of the uraemic syndrome in chronic kidney disease
-
Possible role of microRNAs in CKD progression
-
Urinary proteomics analysis reveals multiple features associated with chronic kidney disease progression
-
- Journal Article
- A1
- open access
Determination of asymmetric and symmetric dimethylarginine in serum from patients with chronic kidney disease: UPLC-MS/MS versus ELISA
-
Disruption, but not overexpression of urate oxidase alters susceptibility to pentylenetetrazole- and pilocarpine-induced seizures in mice
-
Concentrations of representative uremic toxins in a healthy versus uremic pediatric population
-
Estimated GFR poorly relfects the concentration of various uremic toxins in pediatric CKD patients
-
Uric acid is released in the brain during seizure activity and increases severity of seizures in a mouse model for acute limbic seizures
-
Levels of indoxyl sulfate in kidney transplant patients, and the relationship with hard outcomes
-
Future avenues to decrease uremic toxin concentration
-
- Journal Article
- A1
- open access
Protein-bound uremic toxin profiling as a tool to optimize hemodialysis
-
Association of advanced age with concentrations of uraemic toxins in CKD
-
Exploring protein binding of uraemic toxins in chronic kidney disease and haemodialysis patients
-
- Journal Article
- A2
- open access
The intestine and the kidneys : a bad marriage can be hazardous
-
- Journal Article
- A2
- open access
Uraemic toxins and new methods to control their accumulation : game changers for the concept of dialysis adequacy
-
- Journal Article
- A2
- open access
Chronic kidney disease and fibrosis : the role of uremic retention solutes
-
High-resolution plasma proteome analysis identifies new changes in molecular mechanisms involved in chronic kidney disease
-
Urinary proteomics to decipher molecular pathophysiology of CKD progression
-
Pro-inflammatory cytokines and leukocyte oxidative burst in chronic kidney disease: culprits or innocent bystanders?
-
Protein-bound uraemic toxins, dicarbonyl stress and advanced glycation end products in conventional and extended haemodialysis and haemodiafiltration
-
Once upon a time in dialysis: the last days of Kt/V?
-
New insights in molecular mechanisms involved in chronic kidney disease using high-resolution plasma proteome analysis
-
Prediction of renal failure in sepsis patients by established CE-MS peptide marker panels
-
- Conference Paper
- C3
- open access
Uraemic toxin concentration variability in HD patients: can we still rely on the results of cross-sectional studies?
-
Exploring mechanisms of protein binding of uraemic toxins in CKD2-5 and haemodialysis patients
-
- Journal Article
- A1
- open access
Exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis
-
Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to measure creatinine in human urine
-
- Journal Article
- A1
- open access
Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury : a prospective cohort study of patients with sepsis
-
- Journal Article
- A1
- open access
Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease : a prospective cohort study
-
- Journal Article
- A1
- open access
Transcriptome analysis in patients with chronic kidney disease on hemodialysis disclosing a key role for CD16⁺CX3CR1⁺ monocytes
-
- Journal Article
- A1
- open access
Protein-bound solute removal during extended multipass versus standard hemodialysis
-
- Journal Article
- A1
- open access
Where and when to inject low molecular weight heparin in hemodiafiltration? : a cross over randomised trial
-
New methods and technologies for measuring uremic toxins and quantifying dialysis adequacy
-
- Journal Article
- A2
- open access
Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients
-
p-Cresyl sulphate has pro-inflammatory and cytotoxic actions on human proximal tubular epithelial cells
-
Introduction: Uremic toxicity: state of the art 2014
-
Elevated soluble tumor necrosis factor alpha receptor 1 and 2 concentrations in hemodialysis patients are not reflected by alterations in membrane expression
-
The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review
-
- Journal Article
- A1
- open access
Looking beyond endotoxin: a comparative study of pyrogen retention by ultrafilters used for the preparation of sterile dialyis fluid
-
AKI in early sepsis is a continuum from transient AKI without tubular damage over transient AKI with minor tubular damage to intrinsic AKI with severe tubular damage
-
Bedside monitoring of anticoagulation in chronic haemodialysis patients treated with tinzaparin
-
- Conference Paper
- C3
- open access
Metabolic profiling of human plasma and urine in chronic kidney disease by hydrophilic interaction liquid chromatography coupled with time-of-flight mass spectrometry: a pilot study
-
State-of-the-art non-targeted metabolomics in the study of chronic kidney disease
-
Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis
-
- Conference Paper
- C3
- open access
Determination of asymmetric and symmetric dimethylarginine in serum from patients with chronic kidney disease : UPLC-MS/MS versus ELISA
-
- Conference Paper
- C3
- open access
Metabolic profiling by hydrophilic interaction ultra-performance liquid chromatography time-of-flight mass spectrometry in the study of chronic kidney disease
-
- Conference Paper
- C3
- open access
LC- and GC-MS-based non-targeted metabolomics in the study of chronic kidney disease
-
Looking further than endotoxin: a comparative study of pyrogen retention by ultrafilters applied for preparation of sterile dialysis fluid
-
The uraemic toxin indoxylsulfate induces leukocyte-endothelial adhesion and induces impaired blood flow in the rat peritoneal microcirculation
-
Assesment of different cut-off levels of serum creatinine increase to predict mortality in septic patients
-
Median term outcome of renal function in patients admitted to ICU with sepsis
-
Predictors associated with short and median-term outcome of patients admitted to ICU with sepsis
-
Does beta-2-microglobulin exert avascular damaging effect by activating leukocytes?
-
A pro-inflammatory change in numbers of monocyte and dendritic cell subtypes occurs early in the course of CKD
-
Non-targeted metabolomics in the study of chronic kidney disease
-
- Journal Article
- A1
- open access
Does the adequacy parameter Kt/V-urea reflect uremic toxin concentrations in hemodialysis patients?
-
Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall
-
Review of protein-bound toxins, possibility for blood purification therapy
-
- Journal Article
- A1
- open access
Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins?
-
Mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma
-
Uremia-related oxidative stress in leukocytes is not triggered by β2-microglobulin
-
An update on uremic toxins
-
p-Cresyl sulfate promotes insulin resistance associated with CKD
-
Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration
-
A novel UPLC–MS–MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients
-
Determination of seven uremic retention toxins in serum of chronic kidney disease patients by UPLC-MS/MS
-
Urinary NGAL at admission does not provide additional information than serum creatinine, urine output and first 24h fluid balance, for prediction of AKI in septic patients at ICU
-
- Conference Paper
- C3
- open access
KT/V is a poor predictor of concentration of a broad range of uremic toxins
-
Prognostic implications of plasma myoglobin levels in patients with chronic kidney disease
-
p-Cresyl sulfate
-
Classification and list of uremic toxins
-
Guanidino compounds
-
Renal hypoperfusion, rather than tubular damage is the main initial event in AKI during early sepsis
-
An update on protein-bound uremic retention solutes
-
An obituary for GFR as the main marker for kidney function?
-
- Journal Article
- A1
- open access
Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease
-
Dialysis water and fluid purity: more than endotoxin
-
Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients
-
In vivo effects of the protein-bound uremic toxins p-cresylsulfate, p-cresylglucuronide and indoxylsulfate on the cross-talk between leukocytes and the vessel wall
-
- Conference Paper
- C3
- open access
Development of an UPLC-MS/MS method for the determination of seven uremic retention toxins in serum of chronic kidney disease patients
-
Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications
-
Warning: the unfortunate end of p-cresol as a uraemic toxin
-
EGFR is a poor predictor of uremic toxin concentrations
-
Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins
-
Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities
-
Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease
-
Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation
-
New uremic toxins: which solutes should be removed?
-
Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation
-
The gut: the forgotten organ in Uremia?
-
Prospective evaluation of the change of predialysis protein-bound uremic solute concentration with postdilution online hemodiafiltration
-
Uremic toxins
-
Advantages of new hemodialysis membranes and equipment
-
Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease
-
- Journal Article
- A1
- open access
Dinucleoside polyphosphates : newly detected uraemic compounds with an impact on leucocyte oxidative burst
-
Uremic Toxins in Acute Kidney Injury
-
Dinucleoside polyphosphates: newly detected uremic compounds with an impact on leukocyte oxidative burst
-
Evolution of protein-bound uraemic solutes during predilution haemofiltration
-
Platelet/Leukocyte Activation, Inflammation, and Uremia
-
Genetics/Genomics in Chronic Kidney Disease-Towards Personalized Medicine?
-
Guanidino Compounds as Uremic (Neuro)Toxins
-
Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients
-
Flow cytometric calcium flux assay: evaluation of cytoplasmic calcium kinetics in whole blood leukocytes
-
The Role of EUTox in Uremic Toxin Research
-
SYMMETRIC DIMETHYLARGININE (SDMA):A PRO-INFLAMMATORY UREMIC TOXIN ENHANCING CELLULAR CALCIUM INFLUX AND ACTIVATING NF kappa B
-
EFFECTIVE REMOVAL OF UREMIC SOLUTES BY DIFFERENT CONVECTIVE STRATEGIES: A PROSPECTIVE CROSS-OVER TRIAL.
-
Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes
-
Granulocyte-inhibitory proteins and other proteinaceous molecules in acute kidney injury
-
Metabolic waste products in acute uremia
-
Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial
-
A novel bio-assay increases the detection yield of microbiological impurity of dialysis fluid, in comparison to the LAL-test
-
- Journal Article
- A2
- open access
Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies
-
The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity?
-
A bench to bedside view of uremic toxins
-
From uremic toxin retention to removal by convection: do we know enough?
-
What is new in uremic toxicity?
-
Vitamin D binding protein and the need for vitamin D in hemodialysis patients
-
Impact of hemodialysis duration on the removal of uremic retention solutes
-
Uremic toxins: do we know enough to explain uremia?
-
Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro - towards a standardized approach for research on uraemia (vol 22, pg 3381, 2007)
-
Uremic toxins in chronic renal failure
-
A novel highly efficient bio-assay to monitor microbiological purity of dialysis fluids
-
Clearance of urea and difficult to remove uremic toxins when modifying dialysis time only
-
Impact of dialysis time on the removal of urea and difficult to remove uremic toxins
-
The impact of modifying only dialysis duration on the removal of uremic toxins
-
Review on uraemic solutes II: variability in reported concentrations: causes and consequences
-
Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro - towards a standardized approach for research on uraemia
-
Pigmentation markers: more color in the picture of uremic toxicity?
-
P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production
-
Diadenosine polyphosphates: newly detected uremic compounds with an impact on leukocyte oxidative burst activity
-
The guanidine SDMA which previously was considered inert, has a leukocyte stimulating effect
-
Impact of iron sucrose therapy on leucocyte surface molecules and reactive oxygen species in haemodialysis patients
-
Clamping of the dialysate outlet line in the Genius (R) dialysis system does not alter dialysate flow or clearances
-
New insights in uremic toxicity
-
Effect of specific guanidino compounds retained in uremia on the respiratory burst activity of leukocytes
-
Diadenosine polyphosphates: newly detected uremic compounds with an impact on the leukocyte oxidative burst activity
-
Modification of leukocyte response by phenolic protein-bound uremic retention solutes
-
Dialysate partitioning in the Genius (R) batch hemodialysis system: Effect of temperature and solute concentration
-
P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro
-
Interleukin/cytokine profiles in haemodialysis and in continuous peritoneal dialysis
-
In vitro evidence for immune activating effect of specific AGE structures retained in uremia.
-
In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection
-
Low water-soluble uremic toxins
-
In vitro study of the potential role of guanidines in uremia-related atherogenesis and infection
-
Immune stimulating effect of genuine uremic AGEs